申请人:ASTRAZENECA AB
公开号:WO2004009580A1
公开(公告)日:2004-01-29
There are provided novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, M, T, U, Y, V and W are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
提供了式(I)的新化合物,其中R1、R2、R3、R4、R5、R6、R7、M、T、U、Y、V和W如规范所定义,并且其药学上可接受的盐;以及它们的制备方法、含有它们的组合物和它们在治疗中的使用。这些化合物是一氧化氮合酶抑制剂,因此在治疗或预防炎症性疾病和疼痛方面特别有用。